BIODLINK-B (01875) announced that effective April 29, 2026, Mr. Fu Shan has resigned from his positions as the company's executive director, chairman of the board, and member and chairman of the nomination committee and the strategy and ESG committee. Dr. Liu Weidong has resigned as a non-executive director and member of the audit and connected transactions committee and the strategy and ESG committee. Ms. Sun Hui has resigned as an independent non-executive director, member and chairman of the audit and connected transactions committee, and member of the nomination committee. Mr. Zhang Qing has resigned as an independent non-executive director, member of the audit and connected transactions committee, and member and chairman of the remuneration committee. Dr. Gu Xuelin has resigned as an independent non-executive director and member of the remuneration committee, nomination committee, and strategy and ESG committee.

Concurrently, Dr. Li Jincai has been appointed as an executive director, chairman of the board, chairman of the nomination committee, chairman of the strategy and ESG committee, and a member of the remuneration committee. Mr. Xi Xiaojie has been appointed as a non-executive director and a member of the audit and connected transactions committee and the strategy and ESG committee. Mr. Fan Xin has been appointed as an independent non-executive director, chairman of the audit and connected transactions committee, and a member of the remuneration committee. Dr. Ulf Grawunder has been appointed as an independent non-executive director, chairman of the remuneration committee, and a member of the nomination committee and the strategy and ESG committee. Dr. Hu Zhaohong has been appointed as an independent non-executive director and a member of the audit and connected transactions committee and the nomination committee.